8CT.F · Cannabix Technologies Inc

-

Please sign in to comment on 8CT.F

1 Comment

Admin

3 years, 7 months ago

Cannabix Technologies Inc is currently in a long term uptrend where the price is trading 11.2% above its 200 day moving average.

From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.0.

Cannabix Technologies Inc's total revenue sank by nan% to $0 since the same quarter in the previous year.

Its net income has dropped by 1271.4% to $-7M since the same quarter in the previous year.

Finally, its free cash flow fell by 5.5% to $-518K since the same quarter in the previous year.

Based on the above factors, Cannabix Technologies Inc gets an overall score of 2/5.

Industry	Medical Devices
Sector	Healthcare
ISIN	CA13765L1013
CurrencyCode	EUR
Exchange	F

Market Cap	27M
Beta	2.46
Dividend Yield	0.0%
Target Price	None
PE Ratio	None

ABOUT

Cannabix Technologies Inc

Cannabix Technologies Inc., a technology company, develops marijuana breathalyzer for employers, law enforcement, governments, and public in North America. It develops tetrahydrocannabinol breath analyzers, a point of care breath testing tool for the rapid detection of recent cannabis use, as well as breath collection units. The company was formerly known as West Point Resources Inc. and changed its name to Cannabix Technologies Inc. in August 2014. Cannabix Technologies Inc. was incorporated in 2011 and is based in Burnaby, Canada.

8CT.F · Cannabix Technologies Inc

-

Cannabix Technologies Inc

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Cannabix Technologies Inc using a moving average strategy